Risedronate is a treatment for a bone weakening disease (Paget's disease).The drug helps relieve bone pain and can prevent long-term complications of the disease.

Market Analysis and Insights: Global and North America Risedronate Sodiums Market
This report focuses on global and North America Risedronate Sodiums market.
In 2020, the global Risedronate Sodiums market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In North America the Risedronate Sodiums market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Risedronate Sodiums Scope and Market Size
Risedronate Sodiums market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Risedronate Sodiums market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For North America market, this report focuses on the Risedronate Sodiums market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in North America.

Segment by Type
Troche
Capsule

Segment by Application
Hospital
Clinic
Drugstore
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Allergan
Sanofi
Teva Pharmaceuticals USA, Inc.
Mylan
Apotex Inc
Macleods Pharmaceuticals Limited
Sun Pharmaceutical Industries Ltd
Beijing SL Pharmaceutical Co.,Ltd.
Changzhou Watson Pharmaceuticals Co., Ltd